Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.28 EUR 4.59% Market Closed
Market Cap: €49.8m
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one BNN stock under the Base Case scenario is 2.41 EUR. Compared to the current market price of 2.28 EUR, BRAIN Biotech AG is Undervalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BNN Relative Value
Base Case
2.41 EUR
Undervaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

BNN Competitors Multiples
BRAIN Biotech AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
BRAIN Biotech AG
XETRA:BNN
49.8m EUR 1 -4.2 -19.4 -5.9
US
Sherwin-Williams Co
NYSE:SHW
90.6B USD 3.9 35.4 22.8 26.7
US
Ecolab Inc
NYSE:ECL
85.5B USD 5.4 43.1 24.4 32.7
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.2T JPY 4 21 10.1 14
CN
Wanhua Chemical Group Co Ltd
SSE:600309
278.7B CNY 1.6 25.1 21.5 21.5
CH
Givaudan SA
SIX:GIVN
28.4B CHF 3.8 26.1 17.7 22.3
US
PPG Industries Inc
NYSE:PPG
29.3B USD 1.8 18.6 12.6 15.4
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.3T INR 6.6 59.7 35.7 43.9
CH
Sika AG
F:SIKA
19.9B EUR 1.3 11.9 8.7 10.9
CH
DSM-Firmenich AG
AEX:DSFIR
18.4B EUR 1.4 73.2 10.1 35.7
P/E Multiple
Earnings Growth PEG
DE
BRAIN Biotech AG
XETRA:BNN
Average P/E: 36.9
Negative Multiple: -4.2 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
35.4
15%
2.4
US
Ecolab Inc
NYSE:ECL
43.1
9%
4.8
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
21
7%
3
CN
Wanhua Chemical Group Co Ltd
SSE:600309
25.1
13%
1.9
CH
Givaudan SA
SIX:GIVN
26.1
6%
4.3
US
PPG Industries Inc
NYSE:PPG
18.6
11%
1.7
DK
Novozymes A/S
CSE:NZYM B
54.8
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
59.7
16%
3.7
CH
Sika AG
F:SIKA
11.9
5%
2.4
CH
D
DSM-Firmenich AG
AEX:DSFIR
73.2
67%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
BRAIN Biotech AG
XETRA:BNN
Average EV/EBITDA: 19.2
Negative Multiple: -19.4 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
22.8
7%
3.3
US
Ecolab Inc
NYSE:ECL
24.4
9%
2.7
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.1
4%
2.5
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.5
33%
0.7
CH
Givaudan SA
SIX:GIVN
17.7
5%
3.5
US
PPG Industries Inc
NYSE:PPG
12.6
9%
1.4
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
35.7
11%
3.2
CH
Sika AG
F:SIKA
8.7
4%
2.2
CH
D
DSM-Firmenich AG
AEX:DSFIR
10.1
7%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
BRAIN Biotech AG
XETRA:BNN
Average EV/EBIT: 26.1
Negative Multiple: -5.9 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
26.7
10%
2.7
US
Ecolab Inc
NYSE:ECL
32.7
12%
2.7
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
14
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.5
8%
2.7
CH
Givaudan SA
SIX:GIVN
22.3
5%
4.5
US
PPG Industries Inc
NYSE:PPG
15.4
8%
1.9
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
43.9
11%
4
CH
Sika AG
F:SIKA
10.9
5%
2.2
CH
D
DSM-Firmenich AG
AEX:DSFIR
35.7
36%
1

See Also

Summary
BNN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BNN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BNN stock valuation using valuation multiples.
Wall Street Estimates
BNN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BNN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.